SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings, Broadcom's stock is trending due to a sharp pullback, sparking debates about market manipulation and AI sector overvaluation. Community members are actively discussing potential support levels and whether the dip represents a buying opportunity or a sign of further decline. Analyst price target updates add to the uncertainty, with some traders anticipating a rebound while others brace for continued volatility.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to discussions around its low float and potential for a short squeeze, with community members comparing it to other high-flying stocks. Traders are actively watching key resistance levels and speculating on possible price targets, while also weighing concerns about the company's valuation and potential for a pullback. The stock's association with the robotics sector and its connection to AMC through its name are also contributing to the ongoing conversation.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco ($COST) is trending due to a recent analyst downgrade from Roth Capital, sparking debate about its valuation and growth prospects, especially compared to competitors like Walmart. The community is discussing whether this presents a buying opportunity or signals deeper concerns about membership growth and market saturation. Some investors are also closely watching for any news regarding a potential stock split or special dividend announcement.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to its nano float and Hong Kong connection, with traders anticipating a potential run similar to other low-float stocks. Community members cite recent acquisitions and revenue growth as catalysts, while also highlighting its low market capitalization. The stock's high borrow rate and potential for a short squeeze are also fueling interest.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to community excitement around its potential for a short squeeze, with many noting bullish technical formations and anticipating a breakout. The stock is also gaining attention due to positive interim data from its RAD 101 clinical trial, leading to speculation about future sales and potential buyout offers. Community members are actively discussing target prices and the possibility of the stock reaching significantly higher levels.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that the cannabis industry could be on the verge of significant reform, with community members closely watching for potential executive action. The central talking point revolves around the possibility of reclassification, with many expressing mixed sentiment due to the long history of the stock. Despite the hype, some traders are wary, pointing to past disappointments.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending as traders discuss a recent FDA Fast Track designation for its AlloNK therapy in refractory rheumatoid arthritis, with Wedbush setting a price target. Community members highlight the potential for a significant squeeze, referencing low float and high borrow rates. Some caution around potential offerings and the stock's volatile price action.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to community hype around a potential short squeeze, fueled by its low float and comparisons to previous runners. Discussions highlight updated analyst target prices and the stock's volatile price action, with some traders anticipating a significant breakout. Community members are closely monitoring key price levels as potential triggers for further upward momentum.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors assess the implications of its AI strategy and recent partnerships, with community discussions focusing on whether the company can maintain its growth trajectory amidst rising competition. Recent reports of a potential acquisition of cybersecurity firm Armis for $7B has sparked debate about valuation and strategic fit, contributing to market volatility. Despite long-term bullish sentiment from analysts, the stock's YTD performance has some questioning its current valuation and potential for short-term recovery.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending downwards, sparking debates about averaging down and the health of the data center trade. Community members are attributing the price drop to institutional repositioning or short pressure, while others remain confident in the company's fundamentals and future contracted revenue, viewing it as a buying opportunity amidst market volatility. Some traders are expressing frustration and hoping for news regarding a hyperscaler tenant to turn things around.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Norges Bank Acquires New Position in Upstream Bio, Inc. $UPB

Norges Bank bought a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The...

Geode Capital Management LLC Buys 235,958 Shares of Upstream Bio, Inc. $UPB

Geode Capital Management LLC boosted its stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) by 57.5% in the second quarter, according to the company in its most recent 13F filing with the...

Upstream Bio (NASDAQ:UPB) Shares Up 8.5% - Should You Buy?

Upstream Bio (NASDAQ:UPB) Shares Up 8.5% - Time to Buy...

Upstream Bio (NASDAQ:UPB) Hits New 12-Month High - What's Next?

Upstream Bio (NASDAQ:UPB) Reaches New 12-Month High - Still a Buy...

Evercore ISI Begins Coverage on Upstream Bio (NASDAQ:UPB)

Evercore ISI assumed coverage on shares of Upstream Bio in a research note on Tuesday. They set an "outperform" rating and a $40.00 price objective for the company...

Upstream Bio (NASDAQ:UPB) Announces Earnings Results

Upstream Bio (NASDAQ:UPB - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.63) earnings per share for the quarter, topping analysts' consensus estimates of ($0.78...

Upstream Bio (UPB) shares saw an increase in after-hours trading on Friday following the company's presentation of pharmacology modeling data, which showed investigational antibody verekitug as potentially more potent than tezepelumab by targeting the TSLP receptor rather than its ligand.Shares of the company finished at $11.36, down by 1.7%, but rose to $11.41 in after-hours trading with a 0.4% gain.Results from the European Academy of Allergy &amp; Clinical Immunology Congress demonstrated that verekitug produced lasting and thorough blockage of the TSLP/TSLPR complex, which drives critical inflammatory diseases, including severe asthma, as well as COPD and chronic rhinosinusitis with nasal polyps (CRSwNP).The FDA-approved antibody Tezspire (tezepelumab), which targets severe asthma, operates through TSLP ligand inhibition and was developed jointly by AstraZeneca and Amgen.The modeling study used a mechanistic PK/PD approach and incorporated clinical and published data.&nbsp;Simulations predicted that verekitug would lead to a greater reduction in fractional exhaled nitric oxide (FeNO)—a biomarker for airway inflammation—compared to tezepelumab.The company is looking to assess top-line Phase 2 data in CRSwNP later this year, and in severe asthma in the first half of 2026.”Verekitug is the only known monoclonal antibody in clinical development that directly targets the TSLP receptor, offering what the company describes as a more upstream and durable blockade of the inflammatory cascade.The stock moved higher after the release, with investors responding positively to the strengthened differentiation case for verekitug as it advances through multiple Phase 2 trials.&nbsp;These include the Valiant study in severe asthma, the Vibrant trial in CRSwNP, and a planned trial in COPD.Upstream Bio previously reported favorable tolerability, high subcutaneous bioavailability, and a consistent pharmacokinetic profile for verekitug in completed Phase 1 studies.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.Upstream’s stock has declined 30.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency

The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases.

Equity

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Current Price	$27.48
Prev Close	$27.14
Open	$27.67
Dividend Yield	0.00%
50-Day Moving Average	$24.18
Beta	1.13
Avg. Volume	462,392.79
PE Ratio	-11.88

52-Week High	$33.00
52-Week Low	$5.14
Market Capitalization	$1.47B
EPS (Annual)	-$1.43
Price to Book	3.87
Revenue Per Employee	$45,576.92
Enterprise Value/EBITDA	N/A

UPB
Upstream Bio Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UPB News

UPBUpstream Bio Inc.